Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody.

Thus, 32% of the cases that were scored negative for T5 had tumors larger than 4 cm; in contrast, 73% of the cases that were stained positive for T5 had large tumors ( Table 3 ), differences that are statistically highly significant (p = 0.004).

also in 132,142 other papers